The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Abstract
BACKGROUND: The safety and efficacy of various management strategies for patients receiving oral anticoagulants (OACs) who need to undergo surgery or invasive procedures are unknown. METHODS: We performed a systematic review and synthesis of the English-language literature examining the perioperative management and outcomes of patients receiving long-term OAC therapy. RESULTS: Thirty-one reports were identified. The quality of the identified reports was generally poor; no randomized controlled trials have been performed and duration of follow-up was typically not stated. Overall, 29 thromboembolic events occurred amont 1868 patients (1.6%; 95% confidence interval, 1.0%-2.1%), including 7 strokes (0.4%; 95% confidence interval, 0%-0.7%). Thromboembolic event rates by management strategy were 0.4% (1 of 237) for continuation of OAC, 0.6% (6 of 996) for discontinuation of OAC therapy without administration of intravenous heparin, 0% (0 of 166) for discontinuation of OAC therapy with administration of intravenous heparin, 0.6% (1 of 180) for discontinuation of OAC therapy with administration of low-molecular-weight heparin, and 8.0% (21 of 263) for unspecified or unclear strategies. Major bleeding while receiving therapeutic OAC was rare for dental procedures (0.2% [4 of 2014]), arthrocentesis (0% [0 of 32]), cataract surgery (0% [0 of 203]), and upper endoscopy or colonoscopy with or without biopsy (0% [0 of 111]). CONCLUSIONS: Most patients can undergo dental procedures, arthrocentesis, cataract surgery, and diagnostic endoscopy without alteration of their regimen. For other invasive and surgical procedures, oral anticoagulation needs to be withheld, and the decision whether to pursue an aggressive strategy of perioperative administration of intravenous heparin or subcutaneous low-molecular-weight heparin should be individualized. The current literature is substantially limited in its ability to help choose an optimal strategy. Further and more rigorous studies are needed to better inform this decision.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
Prandoni, P., Lensing, A. W. A., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A. M., Polistena, P., Bernardi, E., & Prins, M. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00001 · Cited by 2,109
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Levine, M., Gent, M., Hirsh, J., Leclerc, J., Anderson, D., Weitz, J., Ginsberg, J., Turpie, A. G., Demers, C., Kovacs, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341101 · Cited by 1,192
Self-citationKoopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
Cannegieter, S. C., Rosendaal, F. R., & Briët, E. (1994) · Circulation · doi:10.1161/01.cir.89.2.635 · Cited by 1,068
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Lärfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506223322501 · Cited by 932
Management of Anticoagulation before and after Elective Surgery
Kearon, C., & Hirsh, J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705223362107 · Cited by 812
Ischemic Stroke Subtypes: A Population-Based Study of Functional Outcome, Survival, and Recurrence
Petty, G. W., Brown, R. D., Whisnant, J. P., Sicks, J. D., O’Fallon, W. M., & Wiebers, D. O. (2000) · Stroke · doi:10.1161/01.str.31.5.1062 · Cited by 715
Gould, M. K., Dembitzer, A. D., Doyle, R. L., Hastie, T. J., & Garber, A. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00003 · Cited by 627
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
van Dongen, C. J., van den Belt, A. G., Prins, M. H., & Lensing, A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001100.pub2 · Cited by 433
Carter, C., Kelton, J., Hirsh, J., Cerskus, A., Santos, A., & Gent, M. (1982) · Blood · doi:10.1182/blood.v59.6.1239.1239 · Cited by 331
McLeod, R. S., Geerts, W. H., Sniderman, K. W., Greenwood, C., Gregoire, R. C., Taylor, B. M., Silverman, R. E., Atkinson, K. G., Burnstein, M., Marshall, J. C., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200103000-00020 · Cited by 233
Recent National Patterns of Warfarin Use in Atrial Fibrillation
Stafford, R. S., & Singer, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.13.1231 · Cited by 225
Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
Sobel, M., McNeill, P. M., Carlson, P. L., Kermode, J. C., Adelman, B., Conroy, R., & Marques, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115198 · Cited by 197
Jh, T. (1978) · JAMA · doi:10.1001/jama.239.8.738 · Cited by 173
Otley, C. C. (1996) · Archives of Dermatology · doi:10.1001/archderm.132.2.161 · Cited by 164
Mok, C. K., Boey, J. Y., Wang, R., Chan, T. K., Cheung, K. L., Lee, P. K., Chow, J. S. F., Ng, R. P., & Tse, T.-F. (1985) · Circulation · doi:10.1161/01.cir.72.5.1059 · Cited by 156
Rebound after cessation of oral anticoagulant therapy: the biochemical evidence
Genewein, U., Haeberli, A., Straub, P. W., & Beer, J. H. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1499.x · Cited by 155
Warfarin Withdrawal: Pharmacokinetic-Pharmacodynamic Considerations
Palareti, G., & Legnani, C. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00003 · Cited by 148
Use of enoxaparin for the chronically anticoagulated patient before and after procedures
Spandorfer, J. M., Lynch, S., Weitz, H. H., Fertel, S., & Merli, G. J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00341-0 · Cited by 146
Katholi, R. E., Nolan, S. P., & McGuire, L. B. (1978) · American Heart Journal · doi:10.1016/0002-8703(78)90080-7 · Cited by 131
Michaud, G. F., Pelosi, F., Noble, M. D., Knight, B. P., Morady, F., & Strickberger, S. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00633-1 · Cited by 127
Blajchman, M. A., Young, E., & Ofosu, F. A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb22507.x · Cited by 105
Hull, R. D., Brant, R., Pineo, G. F., Stein, P. D., Raskob, G. E., & Valentine, K. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.137 · Cited by 86
Dalteparin as Periprocedure Anticoagulation for Patients on Warfarin and at High Risk of Thrombosis
Tinmouth, A. H., Morrow, B., Cruickshank, M., Moore, P., & Kovacs, M. J. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10305 · Cited by 86
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves
Eckman, M. H. (1990) · JAMA · doi:10.1001/jama.1990.03440110079032 · Cited by 85
Grip, L., Blombäck, M., & Schulman, S. (1991) · European Heart Journal · doi:10.1093/eurheartj/12.11.1225 · Cited by 84
KMok, C., JBoey, RWang, KChan, T., LCheung, K., Klee, P., JChow, PNg, R., & FTse, T. (1985) · Circulation · Cited by 68
Gerson, L. B., Gage, B. F., Owens, D. K., & Triadafilopoulos, G. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00958-8 · Cited by 52
Mehra, P., Cottrell, D. A., Bestgen, S. C., & Booth, D. F. (2000) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0278-2391(00)90339-2 · Cited by 51
Prospective Double-Arm Study of Fibrinolysis in Surgical Patients
Kosir, M. A., Schmittinger, L., Barno-Winarski, L., Duddella, P., Pone, M., Perales, A., Lange, P. A., Brish, L. K., McGee, K. H., Beleski, K., et al. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1997.5233 · Cited by 34
Valle, C. J. D., Jazrawi, L. M., Idjadi, J. A., HIEBERT, R. N., Stuchin, S. A., STEIGER, D. J., & Cesare, P. E. D. (2000) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200002000-00006 · Cited by 20
Acute Myocardial Infarction: Selection of Reperfusion Strategies in the Individual Patient
Senges, J., & Schiele, R. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615555 · Cited by 17
Cited by
Authors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501035 · Cited by 1,184
The Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., & Ansell, J. (2008) · Chest · doi:10.1378/chest.08-0675 · Cited by 830
Self-citation
Metadata
- Authors
- Dunn, A. S., & Turpie, A. G. G.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2003-04-28
- Volume
- 163
- Issue
- 8
- Pages
- 901
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2045300917
- Cited by
- 434
- References
- 34
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.